Provenance of the protective property of p21

American Journal of Physiology - Renal Physiology

Volumn 289, Issue 3 58-3, 2005, Pages

  Nath, Karl A ^a  

^a Mayo Clinic   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALMODULIN; CISPLATIN; CYCLIN DEPENDENT KINASE; GROWTH ARREST AND DNA DAMAGE INDUCIBLE PROTEIN 45; MYC PROTEIN; PROCASPASE 3; PROTEIN P21;

ANIMAL CELL; ANTINEOPLASTIC ACTIVITY; CELL FATE; CELL PROTECTION; CYTOTOXICITY; EDITORIAL; HUMAN; HUMAN CELL; KIDNEY INJURY; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FAMILY; REGULATORY MECHANISM; RENAL PROTECTION;

EID: 23944485127     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: 10.1152/ajprenal.00224.2005     Document Type: Editorial

References (26)

1. Al-Douahji M, Brugarolas J, Brown PA, Stehman-Breen CO, Alpers CE, and Shankland SJ. The cyclin kinase inhibitor p21WAF1/CIP1 is required for glomerular hypertrophy in experimental diabetic nephropathy. Kidney Int 56: 1691-1699, 1999.
2. Arany I and Safirstein RL. Cisplatin nephrotoxicity. Semin Nephrol 23: 460-464, 2003.
3. Asada M, Yamada T, Ichijo H, Delia D, Miyazono K, Fukumuro K, and Mizutani S. Apoptosis inhibitory activity of cytoplasmic p21(Cip1/WAF1) in monocytic differentiation. EMBO J 18: 1223-1234, 1999.
4. Coqueret O. New roles for p21 and p27 cell-cycle inhibitors: a function for each cell compartment? Trends Cell Biol 13: 65-70, 2003.
5. Dotto GP. p21(WAF1/Cip1): more than a break to the cell cycle? Biochim Biophys Acta 1471: M43-M56, 2000.
6. Fischer PM and Gianella-Borradori A. Recent progress in the discovery and development of cyclin-dependent kinase inhibitors. Expert Opin Invest Drugs 14: 457-477, 2005.
7. Gartel AL and Tyner AL. The role of the cyclin-dependent kinase inhibitor p21 in apoptosis. Mol Cancer Ther 1: 639-649, 2002.
8. Golsteyn RM. Cdk1 and Cdk2 complexes (cyclin dependent kinases) in apoptosis: a role beyond the cell cycle. Cancer Lett 217: 129-138, 2005.
9. Hiromura K, Pippin JW, Blonski MJ, Roberts JM, and Shankland SJ. The subcellular localization of cyclin dependent kinase 2 determines the fate of mesangial cells: role in apoptosis and proliferation. Oncogens 21: 1750-1758, 2002.
10. Inguaggiato P, Gonzalez-Michaca L, Croatt AJ, Haggard JJ, Alam J, and Nath KA. Cellular overexpression of heme oxygenase-1 up-regulates p21 and confers resistance to apoptosis. Kidney Int 60: 2181-2191. 2001.
11. Jackman M, Kubota Y, den Elzen N, Hagting A, and Pines J. Cyclin A- and cyclin E-Cdk complexes shuttle between the nucleus and the cytoplasm. Mol Biol Cell 13: 1030-1045, 2002.
12. Kaushal GP, Kaushal V, Hong X, and Shah SV. Role and regulation of activation of caspases in cisplatin-induced injury to renal tubular epithelial cells. Kidney Int 60: 1726-1736, 2001.
13. Megyesi J, Andrade L, Vieira JM Jr, Safirstein RL, and Price PM. Positive effect of the induction of p21WAF1/CIP1 on the course of ischemic acute renal failure. Kidney Int 60: 2164-2172, 2001.
14. Megyesi J, Andrade L, Vieira JM Jr, Safirstein RL, and Price PM. Coordination of the cell cycle is an important determinant of the syndrome of acute renal failure. Am J Physiol Renal Physiol 283: F810-F816, 2002.
15. Megyesi J, Price PM, Tamayo E, and Safirstein RL. The lack of a functional p21 (WAF1/CIP1) gene ameliorates progression to chronic renal failure. Proc Natl Acad Sci USA 96: 10830-10835, 1999.
16. Megyesi J, Safirstein RL, and Price PM. Induction of p21WAF1/CIP1/SDI1 in kidney tubule cells affects the course of cisplatin-induced acute renal failure. J Clin Invest 101: 777-782, 1998.
17. Megyesi J, Udvarhelyi N, Safirstein RL, and Price PM. The p53-independent activation of transcription of p21 WAF1/CIP1/SDI1 after acute renal failure. Am J Physiol Renal Fluid Electrolyte Physiol 271: F1211-F1216, 1996.
18. Nowak G, Price PM, and Schnellmann RG. Lack of a functional p2 IWAF1/CIP1 gene accelerates caspase-independent apoptosis induced by cisplatin in renal cells. Am J Physiol Renal Physiol 285: F440-F450, 2003.
19. O'Reilly MA. Redox activation of p21Cip1/WAF1/Sdi1: a multifunctional regulator of cell survival and death. Antioxid Redox Signal 7: 108-118, 2005.
20. Portilla D. Energy metabolism and cytotoxicity. Semin Nephrol 23: 432-438, 2003.
21. Price PM, Megyesi J, and Safirstein RL. Cell cycle regulation: repair and regeneration in acute renal failure. Semin Nephrol 23: 449-459, 2003.
22. Price PM, Safirstein RL, and Megyesi J. Protection of renal cells from cisplatin toxicity by cell cycle inhibitors. Am J Physiol Renal Physiol 286: F378-F384, 2004.
23. Ramesh G and Reeves WB. TNF-α mediates chemokine and cytokine expression and renal injury in cisplatin nephrotoxicity. J Clin Invest 110: 835-842, 2002.
24. Shankland SJ and Wolf G. Cell cycle regulatory proteins in renal disease: role in hypertrophy, proliferation, and apoptosis. Am J Physiol Renal Physiol 278: F515-F529, 2000.
25. Weinberg WC and Denning MF. P21Wafl control of epithelial cell cycle and cell fate. Crit Rev Oral Biol Med 13: 453-464. 2002.
26. Yu F, Megyesi J, Safirstein RL, and Price PM. Identification of the functional domain of p21WAF1/CIP1 that protects cells from cisplatin cytotoxicity. Am J Physiol Renal Physiol 289: F514-F520, 2005.